|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash | |||||||||
| Other receivable | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Long-term prepaid expenses | |||||||||
| Marketable securities held in Trust Account | |||||||||
| Deferred financing costs | |||||||||
| Total Assets | |||||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit | |||||||||
| Accrued expenses and accounts payable | |||||||||
| Accrued offering costs and expenses | |||||||||
| Advances from related parties | |||||||||
| Due to related party | |||||||||
| Deferred liabilities | |||||||||
| Deferred underwriting discount | |||||||||
| Promissory note - related party | |||||||||
| Total current liabilities | |||||||||
| Warrant liability | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 26,514,780 shares at redemption value of $10.25 and $10.14 per share as of March 31, 2023 and December 31, 2022, respectively | |||||||||
| Class A ordinary shares subject to redemption | |||||||||
| Total class A ordinary shares subject to possible redemption, 26,514,780 shares at redemption value of $10.25 and $10.14 per share as of March 31, 2023 and December 31, 2022, respectively | |||||||||
| Shareholders' Deficit: | |||||||||
| Common stock | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Class B Ordinary Shares | |||||||||
| Total Shareholders' Deficit | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...
